Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Take a Hint from Gold Prices and Run from Wells Fargo Stock

What many investors need to realize before gambling on Wells Fargo stock is that gold prices are rising. Given that gold is just a commodity, this should clue you in regarding the viability of WFC.

Penny Stock Naked Brand Has Gone From Bad To Worse

It can be fun to invest in penny stocks sometimes, but there's no point in owning NAKD stock, which is dirt cheap for a good reason.

FuelCell Investors May Be in for a Very Scary Halloween

FCEL stock has been dropping after a poor earnings report. Unfortunately, FuelCell doesn't have any immediate catalyts in place to reverse its fortunes.

There Are So Many Better Airline Bets Than Debt-Laden American Airlines Stock

Muddying the waters for American and other carriers is the still weak domestic economy. Weekly jobless claims checked in at 884,000 for the week ending Sept. 5, rising for a fourth consecutive week and easily topping economists' forecasts calling for 840,000 claims. Accounting for nearly 839,000 workers filing under the Pandemic Unemployment Assistance Act, the true claims number was 1.69 million.

Luckin Stock: Investors Can Still Get Burned

The company has gone through a terrible accounting scandal. But unfortunately, the impact will likely be long-lasting for Luckin stock.

Luckin Coffee Stock Is Still Looking Terrible

The Chinese coffee giant defaulted on a major loan and fudged its sales, making Luckin stock untouchable until reform is beyond a doubt.

Sorrento Therapeutics Is An Ailing Investment

Already in financial distress, SRNE stock has too much riding on a Covid-19 spit test that lags far behind one released by Yale University.

If the FDA Can’t Help Ocugen Stock, You Have to Wonder Who Can

Because of the pandemic, OCGN stock attracts speculative interest. But it is not likely to pay off in the long-run

Avoid General Electric Amid the Current Stock Market Dip

GE stock doesn't have the fundamentals or the technicals to justify a long position. Ignore this name for now, even amid a marketwide dip.

As iBio Stock Fades, It’s Time to Look Elsewhere for a Vaccine Play

A few months ago, there was lots of optimism for IBIO stock. But unfortunately, the company has not been able to live up to the lofty expectations.

Don’t Believe the Buzz Surrounding SPAQ Stock

Fisker is waving some red flags, making SPAQ stock unappealing at this point. Investors would be better off selling their shares.

The Recovery for United Airlines Just Isn’t Happening

United was forced to cut its guidance and capacity projections for the third quarter. Without a vaccine, there's no growth in UAL stock.

Why You Should Stay Away From Genius Brands Stock

Stay away from Genius Brands stock even though it has cratered. GNUS stock is worth at best only 46 cents per share, implying an expected drop of 56% from here.

As ‘EV Mania’ Cools, Take The Money and Run with Nio Stock

But, as investors take profit with Tesla, it's time to do the same with Nio stock. With shares more likely to head lower than higher, we may have reached a near-term top.

Speculating in Re-Emerging Whiting Petroleum Stock Remains a No-No

The troubled Denver oil company is back from Chapter 11, but investors should pass on WLL stock and put their money on better alternatives.

Cannabis Bulls Can Do Better Than Tilray Stock

TLRY stock has faded of late — and may continue to do so. There simply isn't a compelling reason to own the stock in a sector with better opportunities.

All This Intense Interest in Marathon Oil Stock Is Just Another Fad

Don't get sucked into the hype surrounding MRO stock. The energy sector is in a precarious position and MRO isn't well-equipped to deal with it.

It’s Time to Admit There’s Just Too Much Still Wrong With Luckin Stock

There is little reason for shareholders to stay optimistic about Luckin stock's future

Marathon Patent Needs a Long-Term Growth Story to Prosper

MARA stock is rallying due to its $100 million shelf registration and new machine purchases but its not enough to justify a buy rating.